XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Retained Earnings
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2021   120,000,000      
Beginning balance, value at Dec. 31, 2021 $ 1,988 $ 1 $ 1,630 $ 357 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 51     51  
Activity related to share-based compensation 4   4    
Derivative instrument adjustments, net of tax 22       22
Ending balance (in shares) at Mar. 31, 2022   120,000,000      
Ending balance, value at Mar. 31, 2022 $ 2,065 $ 1 1,634 408 22
Beginning balance (in shares) at Dec. 31, 2022 113,628,706 113,000,000      
Beginning balance, value at Dec. 31, 2022 $ 2,151 $ 1 1,582 529 39
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 73     73  
Activity related to share-based compensation (in shares)   1,000,000      
Activity related to share-based compensation 3   3    
Derivative instrument adjustments, net of tax (10)       (10)
Repurchase and retirement of common stock (in shares)   (2,000,000)      
Repurchase and retirement of common stock $ (85)   (26) (59)  
Ending balance (in shares) at Mar. 31, 2023 112,515,473 112,000,000      
Ending balance, value at Mar. 31, 2023 $ 2,132 $ 1 $ 1,559 $ 543 $ 29